Search
for
Sort by
Research 271–300 of 1000+
- Treatment of Lichen Planopilaris With Abrocitinib
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Ruxolitinib for the treatment of severe alopecia areata
- Baricitinib Induced Hypoglycemic Seizures in a Patient with Hair Loss and Type I Diabetes Mellitus: A Case Report
- Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with <i>AIRE</i> gene mutation (autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy, APECED syndrome) treated with ruxolitinib
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Skin Biology and Ageing
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Public Interest in JAK Inhibitors for Alopecia Areata: A Google Trend Analysis (Preprint)
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison